1. Home
  2. CTMX vs CRMT Comparison

CTMX vs CRMT Comparison

Compare CTMX & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • CRMT
  • Stock Information
  • Founded
  • CTMX 2008
  • CRMT 1981
  • Country
  • CTMX United States
  • CRMT United States
  • Employees
  • CTMX N/A
  • CRMT N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • CRMT Other Specialty Stores
  • Sector
  • CTMX Health Care
  • CRMT Consumer Discretionary
  • Exchange
  • CTMX Nasdaq
  • CRMT Nasdaq
  • Market Cap
  • CTMX 349.6M
  • CRMT 284.5M
  • IPO Year
  • CTMX 2015
  • CRMT N/A
  • Fundamental
  • Price
  • CTMX $1.93
  • CRMT $32.20
  • Analyst Decision
  • CTMX Strong Buy
  • CRMT Buy
  • Analyst Count
  • CTMX 4
  • CRMT 1
  • Target Price
  • CTMX $5.13
  • CRMT $45.00
  • AVG Volume (30 Days)
  • CTMX 2.4M
  • CRMT 191.0K
  • Earning Date
  • CTMX 11-06-2025
  • CRMT 09-04-2025
  • Dividend Yield
  • CTMX N/A
  • CRMT N/A
  • EPS Growth
  • CTMX 263.20
  • CRMT N/A
  • EPS
  • CTMX 0.49
  • CRMT 1.61
  • Revenue
  • CTMX $141,100,000.00
  • CRMT $1,378,681,000.00
  • Revenue This Year
  • CTMX N/A
  • CRMT $6.23
  • Revenue Next Year
  • CTMX N/A
  • CRMT $5.10
  • P/E Ratio
  • CTMX $3.98
  • CRMT $20.03
  • Revenue Growth
  • CTMX 18.01
  • CRMT 0.64
  • 52 Week Low
  • CTMX $0.40
  • CRMT $32.10
  • 52 Week High
  • CTMX $3.10
  • CRMT $62.72
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 41.17
  • CRMT 25.05
  • Support Level
  • CTMX $1.90
  • CRMT $33.50
  • Resistance Level
  • CTMX $2.16
  • CRMT $37.74
  • Average True Range (ATR)
  • CTMX 0.13
  • CRMT 1.91
  • MACD
  • CTMX -0.01
  • CRMT -0.62
  • Stochastic Oscillator
  • CTMX 7.50
  • CRMT 1.05

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

Share on Social Networks: